Paper40433409
Association of plasma levels of Sestrin2 with adiposity and metabolic function indices in healthy and diabetic subjects from Qatar Biobank.
Zahid MA and 5 others. Front Endocrinol (Lausanne), 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Association of plasma levels of Sestrin2 with adiposity and metabolic function indices in healthy and diabetic subjects from Qatar Biobank. Papers, record 40433409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40433409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association of plasma levels of Sestrin2 with adiposity and metabolic function indices in healthy and diabetic subjects from Qatar Biobank.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adiposity | Major topic |
| Nuclear Proteins | Major topic |
| Diabetes Mellitus | Major topic |
| Biomarkers | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Humans | |
| Male | |
| Female | |
| Qatar | |
| Cross-Sectional Studies | |
| Middle Aged | |
| Adult | |
| Biological Specimen Banks | |
| Insulin Resistance | |
| Metabolic Syndrome | |
| Case-Control Studies | |
| Sestrins |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36133815 | Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36133815 | PubMed |
| 2 | 38792427 | Novel Techniques, Biomarkers and Molecular Targets to Address Cardiometabolic Diseases. | J Clin Med | 2024 | https://conductscience.org/library/papers/38792427 | PubMed |
| 3 | 20067971 | Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. | Diabetes Care | 2010 | https://conductscience.org/library/papers/20067971 | PubMed |
| 4 | 30099048 | Association of serum Sestrin2 level with metabolic risk factors in newly diagnosed drug-naïve type 2 diabetes. | Diabetes Res Clin Pract | 2018 | https://conductscience.org/library/papers/30099048 | PubMed |
| 5 | 25692450 | Upregulation of Sestrin2 expression protects against macrophage apoptosis induced by oxidized low-density lipoprotein. | DNA Cell Biol | 2015 | https://conductscience.org/library/papers/25692450 | PubMed |
| 6 | 16249550 | Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. | Diabetes Care | 2005 | https://conductscience.org/library/papers/16249550 | PubMed |
| 7 | 34979914 | The functions and roles of sestrins in regulating human diseases. | Cell Mol Biol Lett | 2022 | https://conductscience.org/library/papers/34979914 | PubMed |
| 8 | 36841824 | Sestrin2: multifaceted functions, molecular basis, and its implications in liver diseases. | Cell Death Dis | 2023 | https://conductscience.org/library/papers/36841824 | PubMed |
| 9 | 22958918 | Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3. | Cell Metab | 2012 | https://conductscience.org/library/papers/22958918 | PubMed |
| 10 | 36902310 | Sestrin2 as a Protective Shield against Cardiovascular Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902310 | PubMed |
| 11 | 28215577 | Knockdown of sestrin2 increases pro-inflammatory reactions and ER stress in the endothelium via an AMPK dependent mechanism. | Biochim Biophys Acta Mol Basis Dis | 2017 | https://conductscience.org/library/papers/28215577 | PubMed |
| 12 | 30594664 | Sestrin2 increases in aortas and plasma from aortic dissection patients and alleviates angiotensin II-induced smooth muscle cell apoptosis via the Nrf2 pathway. | Life Sci | 2019 | https://conductscience.org/library/papers/30594664 | PubMed |
| 13 | 34116045 | Sestrin2 suppression aggravates oxidative stress and apoptosis in endothelial cells subjected to pharmacologically induced endoplasmic reticulum stress. | Eur J Pharmacol | 2021 | https://conductscience.org/library/papers/34116045 | PubMed |
| 14 | 34699571 | Characterizing epidemiology of prediabetes, diabetes, and hypertension in Qataris: A cross-sectional study. | PLoS One | 2021 | https://conductscience.org/library/papers/34699571 | PubMed |
| 15 | 10477542 | Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. | Circulation | 1999 | https://conductscience.org/library/papers/10477542 | PubMed |
| 16 | 35729499 | The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus. | BMC Cardiovasc Disord | 2022 | https://conductscience.org/library/papers/35729499 | PubMed |
| 17 | 30987118 | Endoplasmic Reticulum Stress: A Critical Molecular Driver of Endothelial Dysfunction and Cardiovascular Disturbances Associated with Diabetes. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30987118 | PubMed |
| 18 | 19067533 | The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. | Metab Syndr Relat Disord | 2008 | https://conductscience.org/library/papers/19067533 | PubMed |
| 19 | 32085772 | The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. | Cardiovasc Diabetol | 2020 | https://conductscience.org/library/papers/32085772 | PubMed |
| 20 | 16150143 | The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. | BMC Cardiovasc Disord | 2005 | https://conductscience.org/library/papers/16150143 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42689222 | Age and sex modify the association between plasma Sestrin2 and bone mineral density: a cross-sectional study. | JBMR Plus | 2026 | https://conductscience.org/library/papers/42689222 | PubMed |
| 42450273 | Microvesicle-Derived Redox Signatures as Mediators of Endothelial Dysfunction in Diabetes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450273 | PubMed |
| 41972739 | Sestrins as Biomarkers of Cellular Stress and Human Disease. | Cells | 2026 | https://conductscience.org/library/papers/41972739 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SESN2 | 83667 | PubTator's text mining | https://conductscience.org/library/genes/83667 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40433409
GET https://conductscience.org/api/papers/v1/40433409/references?page=2